MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR-223 expression is altered during the inflammatory response of various cell types, including granulocytes, macrophages, dendritic cells (DCs), T cells, endothelial cells and epithelial cells.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
Hill, J. M., Zalos, G., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., & Finkel, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022287 · Cited by 3,423
Functional siRNAs and miRNAs exhibit strand bias
Khvorova, A., Reynolds, A., & Jayasena, S. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00801-8 · Cited by 2,645
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
Najafi-Shoushtari, S. H., Kristo, F., Li, Y., Shioda, T., Cohen, D. E., Gerszten, R. E., & Näär, A. M. (2010) · Science · doi:10.1126/science.1189123 · Cited by 957
miR-33 links SREBP-2 induction to repression of sterol transporters
Marquart, T. J., Allen, R. M., Ory, D. S., & Baldán, Á. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005191107 · Cited by 562
Horie, T., Ono, K., Horiguchi, M., Nishi, H., Nakamura, T., Nagao, K., Kinoshita, M., Kuwabara, Y., Marusawa, H., Iwanaga, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008499107 · Cited by 384
Pamukcu, B., Lip, G. Y. H., & Shantsila, E. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.03.025 · Cited by 218
MicroRNAs: novel regulators in skin inflammation
Sonkoly, E., Ståhle, M., & Pivarcsi, A. (2008) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2008.02804.x · Cited by 194
Clinical implications for statin pleiotropy
Liao, J. K. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000191913.16321.60 · Cited by 139
Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis
Price, N. L., Rotllan, N., Canfrán-Duque, A., Zhang, X., Pati, P., Arias, N., Moen, J., Mayr, M., Ford, D. A., Baldán, Á., et al. (2017) · Cell reports · doi:10.1016/j.celrep.2017.10.023 · Cited by 129
High Density Lipoproteins: From Biological Understanding to Clinical Exploitation
(2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-09665-0 · Cited by 86
Efflux and uptake transporters as determinants of statin response
Rodrigues, A. C. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003713519 · Cited by 64
Research works printed but not linked: 89
- Krol, 2010, The widespread regulation of microRNA biogenesis, function and decay, Nat. Rev. Genet., 11, 597, 10.1038/nrg2843 · DOI · Paper page
- Garzon, 2009, MicroRNAs in cancer, Annu. Rev. Med., 60, 167, 10.1146/annurev.med.59.053006.104707 · DOI · Paper page
- Borchert, 2006, RNA polymerase III transcribes human microRNAs, Nat. Struct. Mol. Biol., 13, 1097, 10.1038/nsmb1167 · DOI · Paper page
- Berezikov, 2008, Exploring conservation of transcription factor binding sites with CONREAL, Methods Mol. Biol., 395, 437, 10.1007/978-1-59745-514-5_27 · DOI
- MacRae, 2007, Structural determinants of RNA recognition and cleavage by Dicer, Nat. Struct. Mol. Biol., 14, 934, 10.1038/nsmb1293 · DOI · Paper page
- Ambros, 2003, MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing, Cell, 113, 673, 10.1016/S0092-8674(03)00428-8 · DOI · Paper page
- Yang, 2005, Dicer is required for embryonic angiogenesis during mouse development, J. Biol. Chem., 280, 9330, 10.1074/jbc.M413394200 · DOI · Paper page
- Dessi, 2013, Atherosclerosis, dyslipidemia, and inflammation: the significant role of polyunsaturated fatty acids, ISRN Inflamm., 2013, 191823
- Graham, 2012, Dyslipidemias in the prevention of cardiovascular disease: risks and causality, Curr. Cardiol. Rep., 14, 709, 10.1007/s11886-012-0313-7 · DOI
- Neth, 2013, MicroRNAs in flow-dependent vascular remodelling, Cardiovasc. Res., 99, 294, 10.1093/cvr/cvt096 · DOI
- Raitoharju, 2013, MicroRNAs in the atherosclerotic plaque, Clin. Chem., 59, 1708, 10.1373/clinchem.2013.204917 · DOI
- Raitoharju, 2011, miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study, Atherosclerosis, 219, 211, 10.1016/j.atherosclerosis.2011.07.020 · DOI · Paper page
- Du, 2012, Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification, Arterioscler. Thromb. Vasc. Biol., 32, 2580, 10.1161/ATVBAHA.112.300206 · DOI
- Fan, 2014, MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs, Exp. Mol. Pathol., 96, 242, 10.1016/j.yexmp.2014.02.009 · DOI
- Bianconi, 2018, The regulation and importance of monocyte chemoattractant protein-1, Curr. Opin. Hematol., 25, 44, 10.1097/MOH.0000000000000389 · DOI · Paper page
- Baigent, 2010, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 376, 1670, 10.1016/S0140-6736(10)61350-5 · DOI · Paper page
- Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N. Engl. J. Med., 359, 2195, 10.1056/NEJMoa0807646 · DOI · Paper page
- Hsu, 2012, Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver, J. Clin. Invest., 122, 2871, 10.1172/JCI63539 · DOI · Paper page
- Tsai, 2012, MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis, J. Clin. Invest., 122, 2884, 10.1172/JCI63455 · DOI · Paper page
- Sacco, 2012, MicroRNAs: emerging roles in lipid and lipoprotein metabolism, Curr. Opin. Lipidol., 23, 220, 10.1097/MOL.0b013e3283534c9f · DOI · Paper page
- Gatfield, 2009, Integration of microRNA miR-122 in hepatic circadian gene expression, Genes Dev., 23, 1313, 10.1101/gad.1781009 · DOI · Paper page
- Krützfeldt, 2005, Silencing of microRNAs in vivo with ‘antagomirs’, Nature, 438, 685, 10.1038/nature04303 · DOI · Paper page
- Sun, 2014, MicroRNA-management of lipoprotein homeostasis, Circ. Res., 115, 2, 10.1161/CIRCRESAHA.114.304228 · DOI
- Linsel-Nitschke, 2005, HDL as a target in the treatment of atherosclerotic cardiovascular disease, Nat. Rev. Drug Discov., 4, 193, 10.1038/nrd1658 · DOI · Paper page
- Goedeke, 2014, miRNA regulation of lipoprotein metabolism, Curr. Opin. Lipidol., 25, 282, 10.1097/MOL.0000000000000094 · DOI · Paper page
- Irani, 2016, MicroRNA-30c mimic mitigates hypercholesterolemia and atherosclerosis in mice, J. Biol. Chem., 291, 18397, 10.1074/jbc.M116.728451 · DOI
- Wang, 2012, [The influence of statin therapy on circulating microRNA-92a expression in patients with coronary heart disease], Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 24, 215
- Takahashi, 2010, Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin–angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels, Clin. Sci., 119, 395, 10.1042/CS20100003 · DOI · Paper page
- Takwi, 2012, A statin-regulated microRNA represses human c-Myc expression and function, EMBO Mol. Med., 4, 896, 10.1002/emmm.201101045 · DOI · Paper page
- Tu, 2013, MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention, Cell. Physiol. Biochem., 31, 997, 10.1159/000350117 · doi:10.1159/000350117
- Hu, 2013, Altered microRNA expression in the ischemic–reperfusion spinal cord with atorvastatin therapy, J. Pharmacol. Sci., 121, 343, 10.1254/jphs.12235SC · doi:10.1254/jphs.12235sc
- Rodrigues, 2009, Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells, Eur. J. Pharm. Sci., 37, 486, 10.1016/j.ejps.2009.04.006 · DOI
- Rodrigues, 2016, Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells, Eur. J. Pharm. Sci., 93, 431, 10.1016/j.ejps.2016.08.044 · DOI
- Zhang, 2016, Pitavastatin differentially modulates microRNA-associated cholesterol transport proteins in macrophages, PLoS One, 11
- Ma, 2012, Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130, Nat. Commun., 3, 1291, 10.1038/ncomms2276 · DOI
- Pan, 2009, MicroRNAs regulate CYP3A4 expression via direct and indirect targeting, Drug Metab. Dispos., 37, 2112, 10.1124/dmd.109.027680 · DOI · Paper page
- Liu, 2016, The independent contribution of miRNAs to the missing heritability in CYP3A4/5 functionality and the metabolism of atorvastatin, Sci. Rep., 6, 26544, 10.1038/srep26544 · DOI
- Pocathikorn, 2010, Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells, Clin. Exp. Pharmacol. Physiol., 37, 471, 10.1111/j.1440-1681.2009.05337.x · DOI
- Dubuc, 2004, Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia, Arterioscle. Thromb. Vasc. Biol., 24, 1454, 10.1161/01.ATV.0000134621.14315.43 · DOI · Paper page
- Welder, 2010, High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol, J. Lipid Res., 51, 2714, 10.1194/jlr.M008144 · DOI · Paper page
- Zambrano, 2015, Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study, Int. J. Clin. Exp. Med., 8, 5978
- Zambrano, 2015, Altered microRNome profiling in statin-induced HepG2 cells: a pilot study identifying potential new biomarkers involved in lipid-lowering treatment, Cardiovasc. Drugs Ther., 29, 509, 10.1007/s10557-015-6627-0 · DOI
- Stormo, 2014, RNA-sequencing analysis of HepG2 cells treated with atorvastatin, PLoS One, 9, 10.1371/journal.pone.0105836 · DOI
- Libby, 2012, Inflammation in atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 32, 2045, 10.1161/ATVBAHA.108.179705 · DOI · Paper page
- Swirski, 2013, Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure, Science, 339, 161, 10.1126/science.1230719 · DOI · Paper page
- Nakasa, 2008, Expression of microRNA-146 in rheumatoid arthritis synovial tissue, Arthritis Rheum., 58, 1284, 10.1002/art.23429 · DOI · Paper page
- Taganov, 2006, NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc. Natl. Acad. Sci. U. S. A., 103, 12481, 10.1073/pnas.0605298103 · DOI · Paper page
- Chen, 2007, A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection, J. Biol. Chem., 282, 28929, 10.1074/jbc.M702633200 · DOI · Paper page
- Satoh, 2012, Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal, Immunobiology, 217, 533, 10.1016/j.imbio.2011.08.005 · DOI
- Gojova, 2003, Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice, Blood, 102, 4052, 10.1182/blood-2003-05-1729 · DOI · Paper page
- Liu, 2008, CX 3 CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden, Arterioscler. Thromb. Vasc. Biol., 28, 243, 10.1161/ATVBAHA.107.158675 · DOI · Paper page
- Bobryshev, 1997, Ultrastructural evidence for association of vascular dendritic cells with T-lymphocytes and with B-cells in human atherosclerosis, J. Submicrosc. Cytol. Pathol., 29, 209
- Liu, 2015, Induction of dendritic cell–mediated T-cell activation by modified but not native low-density lipoprotein in humans and inhibition by annexin A5, Arterioscler. Thromb. Vasc. Biol., 35, 197, 10.1161/ATVBAHA.114.304342 · DOI
- Frostegård, 2016, Oxidized low-density lipoprotein (OxLDL)–treated dendritic cells promote activation of T cells in human atherosclerotic plaque and blood, which is repressed by statins: microRNA let-7c is integral to the effect, J. Am. Heart Assoc., 5, 10.1161/JAHA.116.003976 · DOI · Paper page
- Giubilato, 2011, Expansion of CD4+ CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus, Eur. Heart J., 32, 1214, 10.1093/eurheartj/ehq499 · DOI · Paper page
- Sun, 2012, Role of unusual CD4+ CD28− T cells in acute coronary syndrome, Mol. Biol. Rep., 39, 3337, 10.1007/s11033-011-1103-9 · DOI
- Soejima, 2003, Preference toward a T-helper type 1 response in patients with coronary spastic angina, Circulation, 107, 2196, 10.1161/01.CIR.0000066317.23972.CE · DOI
- Xie, 2014, Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway, Cardiovasc. Ther., 32, 276, 10.1111/1755-5922.12098 · DOI
- Scheffer, 2008, Increased plasma apolipoprotein C-III concentration independently predicts cardiovascular mortality: the Hoorn Study, Clin. Chem., 54, 1325, 10.1373/clinchem.2008.103234 · DOI · Paper page
- Zhang, 2008, The cell growth suppressor, mir-126, targets IRS-1, Biochem. Biophys. Res. Commun., 377, 136, 10.1016/j.bbrc.2008.09.089 · DOI · Paper page
- Fish, 2008, miR-126 regulates angiogenic signaling and vascular integrity, Dev. Cell, 15, 272, 10.1016/j.devcel.2008.07.008 · DOI · Paper page
- Wang, 2008, The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis, Dev. Cell, 15, 261, 10.1016/j.devcel.2008.07.002 · DOI · Paper page
- Xu, 2014, Effects of pitavastatin on the expression of VCAM-1 and its target gene miR-126 in cultured human umbilical vein endothelial cells, Cardiovasc. Ther., 32, 193, 10.1111/1755-5922.12081 · DOI
- Pan, 2017, Atorvastatin upregulates the expression of miR-126 in apolipoprotein e-knockout mice with carotid atherosclerotic plaque, Cell. Mol. Neurobiol., 37, 29, 10.1007/s10571-016-0331-x · DOI
- Li, 2014, Chitosan oligosaccharides downregulate the expression of E-selectin and ICAM-1 induced by LPS in endothelial cells by inhibiting MAP kinase signaling, Int. J. Mol. Med., 33, 392, 10.3892/ijmm.2013.1589 · doi:10.3892/ijmm.2013.1589
- Yang, 2015, VCAM-1-targeted silica nanoparticles doped with FITC and Fe3O4 for dual-mode cellular imaging of LPS-induced inflammatory endothelial cells, J. Control. Release, 213, e40, 10.1016/j.jconrel.2015.05.065 · doi:10.1016/j.jconrel.2015.05.065
- Ota, 2010, SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis, J. Atheroscler. Thromb., 17, 431, 10.5551/jat.3525 · DOI
- Jing, 2017, Pitavastatin up-regulate eNOS production by suppressing miR-155 expression in lipopolysaccharide-stimulated human umbilical vein endothelial cells, Cardiovasc. Ther., 35, 10.1111/1755-5922.12282 · DOI
- Sun, 2012, Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase, Hypertension, 60, 1407, 10.1161/HYPERTENSIONAHA.112.197301 · DOI · Paper page
- Yang, 2016, Activation of activator protein 2 alpha by aspirin alleviates atherosclerotic plaque growth and instability in vivo, Oncotarget, 7, 52729, 10.18632/oncotarget.10400 · DOI
- Li, 2016, Inhibition of aberrant microRNA-133a expression in endothelial cells by statin prevents endothelial dysfunction by targeting GTP cyclohydrolase 1 in vivo, Circulation, 134, 1752, 10.1161/CIRCULATIONAHA.116.017949 · DOI
- Minami, 2009, Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease, Eur. J. Clin. Invest., 39, 359, 10.1111/j.1365-2362.2009.02110.x · DOI · Paper page
- Zhang, 2011, Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease, Biochem. Biophys. Res. Commun., 405, 42, 10.1016/j.bbrc.2010.12.119 · DOI
- Liu, 2012, Enhancement of 26S proteasome functionality connects oxidative stress and vascular endothelial inflammatory response in diabetes mellitus, Arterioscler. Thromb. Vasc. Biol., 32, 2131, 10.1161/ATVBAHA.112.253385 · DOI
- Tsimokha, 2014, DNA damage modulates interactions between microRNAs and the 26S proteasome, Oncotarget, 5, 3555, 10.18632/oncotarget.1957 · DOI
- Ludwig, 2005, Effect of statins on the proteasomal activity in mammalian endothelial and vascular smooth muscle cells, Biochem. Pharmacol., 70, 520, 10.1016/j.bcp.2005.04.046 · DOI
- Murray, 2002, The effects of lovastatin on proteasome activities in highly purified rabbit 20S proteasome preparations and mouse MC3T3-E1 osteoblastic cells, Metabolism, 51, 1153, 10.1053/meta.2002.34706 · doi:10.1053/meta.2002.34706
- Wang, 2017, Lovastatin upregulates microRNA-29b to reduce oxidative stress in rats with multiple cardiovascular risk factors, Oncotarget, 8, 9021, 10.18632/oncotarget.14462 · DOI
- Ota, 2007, Sirt1 modulates premature senescence-like phenotype in human endothelial cells, J. Mol. Cell. Cardiol., 43, 571, 10.1016/j.yjmcc.2007.08.008 · DOI · Paper page
- Potente, 2008, Emerging roles of SIRT1 in vascular endothelial homeostasis, Cell Cycle, 7, 2117, 10.4161/cc.7.14.6267 · DOI · Paper page
- Rane, 2009, Downregulation of miR-199a derepresses hypoxia-inducible factor-1α and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes, Circ. Res., 104, 879, 10.1161/CIRCRESAHA.108.193102 · DOI · Paper page
- Saunders, 2010, miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues, Aging (Albany NY), 2, 415, 10.18632/aging.100176 · DOI · Paper page
- Yamakuchi, 2008, miR-34a repression of SIRT1 regulates apoptosis, Proc. Natl. Acad. Sci. U. S. A., 105, 13421, 10.1073/pnas.0801613105 · DOI · Paper page
- Yamakuchi, 2009, MiR-34, SIRT1, and p53: the feedback loop, Cell Cycle, 8, 712, 10.4161/cc.8.5.7753 · DOI · Paper page
- Zhu, 2011, MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1, Cardiovasc. Res., 92, 75, 10.1093/cvr/cvr145 · DOI · Paper page
- Tabuchi, 2012, MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression, Clin. Sci., 123, 161, 10.1042/CS20110563 · DOI · Paper page
- Garrido, 2012, Lysophosphatidic acid pretreatment prevents micromolar atorvastatin-induced endothelial cell death and ensures the beneficial effects of high-concentration statin therapy on endothelial gene expression, Ann. Vasc. Surg., 26, 549, 10.1016/j.avsg.2012.01.005 · doi:10.1016/j.avsg.2012.01.005
- Li, 2017, Atheroprotective effects of statins in patients with unstable angina by regulating the blood-borne microRNA network, Mol. Med. Rep., 16, 817, 10.3892/mmr.2017.6616 · DOI
- Allen, 2017, Pleiotropic and adverse effects of statins—do epigenetics play a role?, J. Pharmacol. Exp. Ther., 362, 319, 10.1124/jpet.117.242081 · DOI
Cited by
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151
“Several studies have been conducted to understand the miR-223 functions that determine its cellular and tissue expression [13, 15, 19-22].”
BackgroundApplication of nanotechnology to improve the therapeutic benefits of statins
Korani, S., Korani, M., Bahrami, S., Johnston, T. P., Butler, A. E., Banach, M., & Sahebkar, A. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.023 · Cited by 51
Self-citationLong noncoding RNAs in endometriosis: Biological functions, expressions, and mechanisms
Wang, X., Zhang, J., Liu, X., Wei, B., & Zhan, L. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.29847 · Cited by 24
Metadata
- Authors
- Mohajeri, M., Banach, M., Atkin, S. L., Butler, A. E., Ruscica, M., Watts, G. F., & Sahebkar, A.
- ORCID
- Banach, Maciej
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 39
- Issue
- 11
- Pages
- 967-981
- ISSN
- 0165-6147
- Cited by
- 48
- References
- 11
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.